Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Zacks Small Cap Research Tweets '$EDSA: @EdesaBiotech - Positive Interim Efficacy Analysis For EB01 Phase 2b Trial In Allergic Contact Dermatitis - https://bit.ly/3z1uGqd by @DavidBautz'


Benzinga | Jun 4, 2021 10:55AM EDT

Zacks Small Cap Research Tweets '$EDSA: @EdesaBiotech - Positive Interim Efficacy Analysis For EB01 Phase 2b Trial In Allergic Contact Dermatitis - https://bit.ly/3z1uGqd by @DavidBautz'

https://twitter.com/ZacksSmallCap/status/1400827427421556742






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC